INTRALESIONAL CORTICOSTEROID INJECTION: AN EFFECTIVE APPROACH FOR POST-BURN HYPERTROPHIC SCARS – A CASE REPORT

Thanh Chơn Nguyễn, Văn Lâm Nguyễn, Hữu Giàu Nguyễn, Trí Minh Phương Ngô, Công Lập Nguyễn, Trần Đăng Khoa Đặng, Trường Hải Đặng

Main Article Content

Abstract

Hypertrophic scar is an abnormal wound healing response characterized by excessive fibroblast proliferation and collagen deposition at the site of injury [9]. Intralesional corticosteroid injection remains one of the main treatment modalities [6]. We report a case of a 20-year-old female presenting with a firm, elevated, violaceous scar on the right ankle following a motorcycle exhaust burn. The lesion developed approximately two months after re-epithelialization, measuring 8×3 cm, without ulceration or discharge. The patient was treated with intralesional corticosteroid injection. After five treatment sessions, the lesion showed significant improvement, becoming softer, flatter, and less erythematous. Through this case, we review the clinical features and treatment outcomes of hypertrophic scars in the literature.

Article Details

References

Trần Vũ Anh Đào, Nguyễn Trọng Hào, Nguyễn Việt Thanh Phúc, Châu Văn Trở. Hiệu quả của tiêm triamcinolone nội thương tổn kết hợp laser xung nhuộm màu trong điều trị sẹo lồi. Tạp chí Y Dược học Phạm Ngọc Thạch. 2023;2(1):155-161. DOI: 10.59715/pntjmp.2.1.19
2. Bao Y, Xu S, Pan Z, et al. Comparative efficacy and safety of common therapies in keloids and hypertrophic scars: a systematic review and meta-analysis. Aesthetic Plast Surg. 2020;44(1): 207–218. DOI: 10.1007/s00266-019-01518-y
3. Huang C, Murphy GF, Akaishi S, et al. Keloids and hypertrophic scars: update and future directions. Plast Reconstr Surg Glob Open. 2013;1(4):e25. DOI:10.1097/gox.0b013e31829c4597
4. Jiang ZY, Liao XC, Liu MZ, Fu ZH, Min DH, Yu XT, Guo GH. Efficacy and safety of intralesional triamcinolone versus combination of triamcinolone with 5-fluorouracil in the treatment of keloids and hypertrophic scars: a systematic review and meta-analysis. Aesthetic Plast Surg. 2020;44(5): 1859-1868. DOI: 10.1007/s00266-020-01721-2
5. Lai IC, Huang GL, Lee KC, et al. Comparative efficacy and recurrence risk of intralesional therapies for hypertrophic scars and keloids: a network meta-analysis. Aesthet Surg J. 2025. DOI: 10.1093/asj/sjaf182
6. Mustoe TA, Cooter RD, Gold MH, et al. International clinical recommendations on scar management. Plast Reconstr Surg. 2002; 110(2): 560–571. DOI:10.1097/00006534-200208000-00031
7. Perdanasari AT, Torresetti M, Grassetti L, et al. Intralesional injection treatment of hypertrophic scars and keloids: a systematic review regarding outcomes. Burns Trauma. 2015;3:14. DOI: 10.1186/s41038-015-0015-7
8. Tschumi C, Plock JA. Intralesional therapy. In: Scars: A Practical Guide for Scar Therapy. Springer; 2024:107–113. DOI: 10.1007/978-3-031-24137-6
9. Wolfram D, Tzankov A, Pülzl P, et al. Hypertrophic scars and keloids: a review of their pathophysiology, risk factors, and therapeutic management. Dermatol Surg. 2009;20(2):171–181. DOI: 10.1111/j.1524-4725.2008.34406.x